Biographical Sketch
Gary W. Falk, MD, is originally from New York City. He received his undergraduate and medical degrees from the University of Rochester and went on to complete his internal medicine residency at George Washington University. He received his gastroenterology training at the University of Michigan.
He joined the staff of the Cleveland Clinic Department of Gastroenterology and Hepatology in 1986 and is currently a professor of medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. He is also Director of the Center for Esophageal and Swallowing Disorders and has previously been Director of the GI Fellowship Training Program at Cleveland Clinic. His research interests focus on Barrett’s esophagus with an emphasis on early detection and prevention of esophageal adenocarcinoma as well as eosinophilic esophagitis.
He is currently an Associate Editor of the American Journal of Gastroenterology and a contributor to the Selected Summaries section of Gastroenterology. He is past President of the American Society for Gastrointestinal Endoscopy.
Specialty Interests
Barrett's Esophagus, Eosinophilic Esophagitis, esophageal diseases, gastroesophageal reflux disease, h. pylori infection, noncardiac chest pain, Peptic Ulcer Disease, Swallowing Disorders
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate
with the pharmaceutical or medical device industries
to help develop medical breakthroughs or provide
medical education about recent trends. The
collaborations are reviewed as part of the Cleveland
Clinic’s procedures. The Cleveland Clinic publicly
discloses payments to its physicians and scientists
for speaking and consulting of
$5,000 or more per year, and any equity, royalties,
and fiduciary relationships in companies with which
they collaborate. In publicly disclosing this
information, the Cleveland Clinic tries to provide
information as accurately as possible about its
doctors’ connections with industry and those of their
immediate family members. As of 8/19/2008, Dr.
Falk has reported the financial relationships
with the companies listed below. Patients should feel
free to contact their doctor about any of the
relationships and how the relationships are overseen
by the Cleveland Clinic. To learn more about the
Cleveland Clinic’s policies on collaborations with
industry and innovation management, go to
our Integrity in Innovation page.
Consulting. Dr. Falk receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
AstraZeneca Pharmaceuticals LP
Olympus
